Pavlovic Smiljana V, Sobic-Saranovic Dragana P, Beleslin Branko D, Ostojic Miodrag C, Nedeljkovic Milan A, Giga Vojislav L, Petrasinovic Zorica R, Artiko Vera M, Todorovic-Tirnanic Mila V, Obradovic Vladimir B
Institute for Nuclear Medicine, Clinical Center of Serbia, Visegradska 26, Belgrade 11000, Serbia.
Nucl Med Commun. 2009 Jan;30(1):68-75. doi: 10.1097/mnm.0b013e32831a40dd.
Optimal treatment for chronic total occlusion (CTO) in the infarct-related coronary artery is not clear. Our aim was to assess myocardial perfusion, left ventricular ejection fraction (EF), and left ventricular size using gated single-photon emission computed tomography (SPECT) myocardial perfusion imaging with 99mTc-methoxy-isobutyl-isonitrile in patients with CTO before and 1 year after recanalization.
Thirty patients with earlier myocardial infarction and at least one CTO underwent percutaneous coronary intervention (PCI) as well as nitrate-enhanced gated SPECT myocardial perfusion and dobutamine stress echocardiography before and 11 +/- 1 months after recanalization. They were divided into three groups based on the outcome of the follow-up angiography: (i) successful recanalization with no evidence of in-stent restenosis (n=13); (ii) successful recanalization with in-stent restenosis (n=7) and (iii) unsuccessful recanalization (n=10).
Overall success of recanalization for CTO was 74%. In group 1, myocardial viability was preserved in 11 of 13 (85%) patients at baseline. Gated SPECT at 1 year showed a significant decrease in perfusion abnormalities (29 +/- 12 to 23 +/- 14%, P < 0.05) and left ventricular end-diastolic volume (EDV) (168 +/- 47 to 151 +/- 47 ml, P < 0.05). Improvement in EF (51 +/- 11 to 54 +/- 13%, P > 0.05) and reduction in left ventricular end-systolic volume (ESV) (84 +/- 37 to 77 +/- 40 ml, P > 0.05) did not reach the level of significance. Myocardial viability was preserved in only two of seven patients (28%) in group 2. Neither mean perfusion abnormalities (37 +/- 24 to 35 +/- 22%, P > 0.05) nor global left ventricular parameters (EF 41 +/- 15 vs. 42 +/- 19%, EDV 298 +/- 33 vs. 299 +/- 57 mL, ESV 197 +/- 12 vs. 195 +/- 32 ml; P > 0.05) changed at the follow-up. In group 3, myocardial viability was preserved in seven of 10 patients (70%) at baseline, but no significant changes in perfusion (40 +/- 18 vs. 41 +/- 19%, P > 0.05) and left ventricular function (EF 42 +/- 17 vs. 44 +/- 14%, EDV 228 +/- 101 vs. 227 +/- 81 ml, ESV 143 +/- 87 vs. 146 +/- 8 ml; P > 0.05) were seen at the follow-up.
Myocardial perfusion and EDV may significantly improve 1 year after PCI provided recanalization of CTO was successful. Our preliminary findings suggest that successful recanalization of CTO may have favorable outcome on left ventricular perfusion and function, particularly in patients with viable myocardium before PCI. The gated SPECT myocardial perfusion imaging with 99mTc-methoxy-isobutyl-isonitrile may be useful for monitoring long-term functional outcome of PCI in patients with CTO.
梗死相关冠状动脉慢性完全闭塞(CTO)的最佳治疗方法尚不清楚。我们的目的是使用99mTc-甲氧基异丁基异腈门控单光子发射计算机断层扫描(SPECT)心肌灌注成像,评估CTO患者再通术前及术后1年的心肌灌注、左心室射血分数(EF)和左心室大小。
30例有早期心肌梗死且至少有一处CTO的患者在再通术前及术后11±1个月接受了经皮冠状动脉介入治疗(PCI)以及硝酸酯增强门控SPECT心肌灌注和多巴酚丁胺负荷超声心动图检查。根据随访血管造影结果将他们分为三组:(i)再通成功且无支架内再狭窄证据(n = 13);(ii)再通成功但有支架内再狭窄(n = 7);(iii)再通失败(n = 10)。
CTO再通的总体成功率为74%。在第1组中,13例患者中有11例(85%)在基线时心肌存活得以保留。1年时的门控SPECT显示灌注异常显著降低(29±12%至23±14%,P < 0.05),左心室舒张末期容积(EDV)降低(168±47 ml至151±47 ml,P < 0.05)。EF改善(51±11%至54±13%,P > 0.05)和左心室收缩末期容积(ESV)降低(84±37 ml至77±40 ml,P > 0.05)未达到显著水平。第2组7例患者中仅有2例(28%)心肌存活得以保留。随访时平均灌注异常(37±24%至35±22%,P > 0.05)和整体左心室参数(EF 41±15%对42±19%,EDV 298±33 ml对299±57 ml,ESV 197±12 ml对195±32 ml;P > 0.05)均未改变。在第3组中,10例患者中有7例(70%)在基线时心肌存活得以保留,但随访时灌注(40±18%对41±19%,P > 0.05)和左心室功能(EF 42±17%对44±14%,EDV 228±101 ml对227±81 ml,ESV 143±87 ml对146±8 ml;P > 0.05)均无显著变化。
如果CTO再通成功,PCI术后1年心肌灌注和EDV可能会显著改善。我们的初步研究结果表明,CTO成功再通可能对左心室灌注和功能产生有利结果,尤其是在PCI术前有存活心肌的患者中。99mTc-甲氧基异丁基异腈门控SPECT心肌灌注成像可能有助于监测CTO患者PCI的长期功能结果。